高樂士公司（NYSE:CLX）第二季度的盈利和收入超出了預期，但其淨銷售額同比下降了15%。管理層重申了對第四季度預測的信心，預計有機銷售將實現中到高個位數的增長，得益於企業資源計劃（ERP）的實施。 事件背景：ERP是高樂士公司正在實施的一項軟件系統升級，用於現代化其核心業務流程，包括供應鏈、財務和其他運營領域。過渡預計將在六個月內分階段完成。 在財報電話會議上，公司CEO琳達·蘭德爾表示：“ERP過渡是我們數字化轉型中非常重要的一步，繼續確保我們擁有數據，並以正確的速度和能力推動增長和生產力。” 雖然公司指導其第三季度有機銷售將實現低個位數增長，受剝離業務和外匯的影響，CFO凱文·雅各布森表示：“ERP過渡將在全年增加1到2個百分點的增長，全部將在第四季度實現。” 重要性：高樂士超出分析師預期，報告收入爲16.9億美元，調整後的每股收益爲$1.55。儘管淨銷售額同比下降了15%，公司提高了毛利率至43.8%，並將運營現金流增加到4.01億美元。 高樂士預計在ERP影響之前，自由現金流目標的11-13%銷售百分比的較高端，ERP實施可能會因庫存增加和預付供應商而使其接近區間的低端。 股價變動：高樂士股價上漲0.69%，週一收於$159.78。追蹤標普500指數的交易所交易基金SPDR S&P 500 ETF Trust（NYSE:SPY）在週一下跌了0.67%，收於$597.77。 根據Benzinga追蹤的22位分析師的平均目標價爲$151.4，評級爲“賣出”，估值範圍從$120到$187。RBC Capital、巴克萊和摩根大通的最新評級建議的目標價爲$150.33，暗示潛在下跌幅度爲3.34%。

以上內容來自Benzinga Earnings專欄，原文如下：

Clorox Co.’s (NYSE:CLX) second-quarter earnings and revenue exceeded expectations, however, its net sales declined 15% annually. The management reinstated confidence in its fourth-quarter forecast expecting mid-to-high-single-digit growth in organic sales driven by the Enterprise Resource Planning (ERP) implementation.

What Happened: ERP refers to a software system upgrade that Clorox is implementing to modernize its core business processes, including supply chain, finance, and other operational areas. The transition is expected to be completed in phases over six months.

During its earnings call the company CEO Linda Rendle said, “ERP transition is a very important step in our digital transformation, continuing to ensure that we have data and can move at the right speed with the right capabilities to enable the growth and productivity that we’re driving.”

While the company guided its third-quarter organic sales to be up low-single digits, with an impact from divestitures and forex, CFO Kevin Jacobsen said, “The ERP transition will add 1 to 2 points of growth over the course of the year, it’s all going to happen in Q4.”

See Also: Illumina Stock Tumbles Nearly 5% Overnight On Robinhood As China Adds ILMN, Calvin Klein Owner PVH To ‘Unreliable Entities List’ Amid Trade War With US

Why It Matters: Clorox exceeded analysts’ expectations, reporting revenue of $1.69 billion and adjusted earnings of $1.55 per share. Despite a 15% decline in year-over-year net sales, the company improved its gross margin to 43.8% and increased operating cash flow to $401 million.

Clorox anticipates being at the higher end of its 11-13% free cash flow target as a percentage of sales before the ERP impact. The ERP implementation will likely bring it closer to the low end of the range due to inventory build and pre-paying suppliers.

Price Action: Shares of Clorox rose 0.69% to end Monday at $159.78 apiece. The exchange-traded fund tracking the S&P 500 index, SPDR S&P 500 ETF Trust (NYSE:SPY) declined 0.67% to $597.77 on Monday.

The average price target among 22 analysts tracked by Benzinga is $151.4 with a ‘sell' rating. The estimates range from $120 to $187 apiece. Recent ratings from RBC Capital, Barclays, and JP Morgan suggest a $150.33 target, implying a potential downside of 3.34%.

Read Next:

• Winner Winner, Chicken Dinner: Tyson Foods Q1 Beat Showcases ‘Improved Execution' In Poultry, Says CEO

Photo courtesy: Shutterstock